News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eddingpharm (Cayman) Inc. To Distribute Two Eli Lilly (LLY) Antibiotics In China



11/10/2016 2:12:44 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Eddingpharm signed a deal with Lilly China to promote and distribute two well-established Lilly antibiotics in China. Ceclor®, marketed in China since 1993, is an oral antibiotic that is used globally. Vancocin®, which entered China in 1996, treats MRSA (methicillin-resistant Staphylococcus aureus). Lilly said it hopes the relationship with Eddingpharm raises the revenues from the vaccines. The company plans to introduce ten new drugs in China over the next decade and wants to focus its resources on other novel products, both established and new-to-China.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES